Lv11
40 积分 2024-06-02 加入
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
1小时前
待确认
Stereotactic body radiotherapy to treat breast cancer oligometastases: A systematic review with meta-analysis
1个月前
已完结
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study
1个月前
已完结
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy
1个月前
已完结
Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer
1个月前
已完结
皖公网安备34019202002308
